Risk factors that may influence the decision to pause treatment include: Being in the dose-escalation phase of GLP-1 therapy Experiencing active gastrointestinal symptoms (nausea, vomiting, bloating) Having known gastroparesis or other conditions affecting gastric emptying Taking concurrent medications that further delay gastric emptying (e.g., opioids) Undergoing procedures with higher aspiration risk (e.g., emergency surgery, airway surgery) If your anaesthetist or surgical team advises temporary cessation based on your individual risk assessment, the timing will depend on the specific medication: Daily injections (such as liraglutide): Typically paused 24 hours before surgery Weekly injections (such as semaglutide, dulaglutide): Often paused with the last dose given at least 7 days before surgery Oral semaglutide (Rybelsus): Usually paused 24 hours before surgery [4] However, these timings may vary according to local NHS Trust protocols and individual clinical assessment

Follow our simple three-step process to restore your energy, balance, and overall wellness
28 Sundar Industrial Estate,N.T.Y Layout Mysore Road , Bangalore - 560026, India Vendor Details Country of origin: India 657 MRP 800.8518% off Save more with additional offers Flat Rs.150 on a Min Transaction of Rs.1000
Lancet (2017)
Metabolic and Mitochondrial Research Assess -oxidation efficiency and mitochondrial energy regulation